Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress
(NASDAQ: ATRA) Delayed: 10.61 --0 (-0%)
Previous Close $10.61    52 Week High $40.80 
Open $10.61    52 Week Low $12.45 
Day High $10.61    P/E N/A 
Day Low $10.61    EPS $0.00 
Volume 85